PDS Biotechnology Corp — Director's Dealing 2015

Oct 8, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edge Therapeutics, Inc. (EDGE)
CIK: 0001472091
Period of Report: 2015-10-06

Reporting Person: BARER SOL J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-06	Common Stock	C	350852	—	Acquired	350852	Indirect
2015-10-06	Common Stock	C	83536	—	Acquired	434388	Indirect
2015-10-06	Common Stock	C	48103	—	Acquired	482491	Indirect
2015-10-06	Common Stock	C	105319	—	Acquired	587810	Indirect
2015-10-06	Common Stock	P	45000	$11	Acquired	632810	Indirect
2015-10-06	Common Stock	J	12735	$6.17	Acquired	645545	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-06	Series B Convertible Preferred Stock	$	C	480000	Disposed		Common Stock (350852)	Indirect
2015-10-06	Series B-1 Convertible Preferred Stock	$	C	114285	Disposed		Common Stock (83536)	Indirect
2015-10-06	Series C Convertible Preferred Stock	$	C	65809	Disposed		Common Stock (48103)	Indirect
2015-10-06	Series C-2 Convertible Preferred Stock	$	C	144086	Disposed		Common Stock (105319)	Indirect

Footnotes

F1: The convertible preferred stock converted into the Issuer's common stock at a conversion ratio, as adjusted to give effect to the Issuer's 1-for-1.3681 reverse stock split effected on September 21, 2015, of one share of common stock for every 1.3681 shares of preferred stock immediately prior to the closing of the Issuer's initial public offering of common stock, and had no expiration date.

F2: These shares are held by Meryl Barer, the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

F3: Meryl Barer, the wife of the Reporting Person received a total of 12,735 shares of the Issuer's common stock, which represented a payment-in-kind dividend on 209,895 shares of the Issuer's convertible preferred stock owned at the time of the dividend payment date. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.